Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

NCT04082000 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped study stopped due to company strategic prioritization

Conditions

Diabetic Neuropathy

Interventions

DRUG: BOL-DP-o-04
DRUG: Placebo

Sponsor

Breath of Life International Pharma Ltd